Manuscripts of interest will present local and global innovations that foster ecosystem efficiencies in telehealth and telemedicine utilizing evidence-based outcomes which include:
Transformation Strategies | Business Models | Workflow | Governance | Recruitment | Training Tools & Tips | Hardware and Software Selection | Oversight | Care Giver Strategies | Provider Strategies | Reimbursement | Population Health | Clinical Study Management & Data Aggregation | Chronic Condition Management | Connected Health | Long-term Care | Remote Health | Behavior Modification | Interoperability | Home – based Care | Staffing Solutions | Reduced Hospital Readmissions | Artificial Intelligence | EMR and PHR | New Technologies & Innovation |
Please note, there are no word counts or limitations. TMT wants you to tell your story, or make a case, in as many words as you need.
Original research: These are detailed studies reporting original research in which telemedicine has played a significant role. They include hypothesis, background study, methods, results, interpretation of findings, and a discussion of possible implications. Randomized, controlled trials, case series, cohort studies, pilot studies, and meta-analysis are also examples of original research that TMT accepts for this category. As applicable, financial, and quality of care implications should also be explored.
Proof of Concept: Demonstrate feasibility to verify real world application, potential value and learnings. Examples such as interoperability, system integration and deployment may be topics. Use cases may also be submitted under this category. If possible, TMT asks the author(s) to include examination of the financial impact the product or service may have on the marketplace.
Review article: Review articles give an overview of existing literature, with emphasis on telemedicine, often identifying specific problems or issues and analyzing information from available published work on the topic with a balanced perspective. Review articles can be of three types: literature reviews, systematic reviews, and meta-analyses. The goal of this article type is to identify specific problems or issues and analyze information from available published work on the topic with a balanced perspective. Note: meta-analyses should be submitted as original research.
Clinical case study: Clinical case studies present the details of real patient cases from medical or clinical practice in which telemedicine played a significant role. The cases presented are usually those that contribute significantly to the existing knowledge on the field. The study is expected to discuss signs, symptoms, diagnosis, and treatment of a disease.
Clinical trial: Clinical trials describe the methodology, implementation, and results of controlled studies in which telemedicine played a significant role. Please see “Format” and “Manuscript” sections below under “Journal Information.”
Technological Report: These reports focus on telehealth innovations in healthcare. Priority is given to papers on the technical underpinnings of an initiative presented in a manner that informs influencers in making decisions in this space. For example, relevant pragmatic work on change management, human factors, and design thinking that accompany innovation should include actual implementation experience whenever available. Reports of metrics to measure these components is highly recommended.
Perspective, opinion, and interview: These are scholarly reviews of fundamental concepts or prevalent ideas in a field of telemedicine. A perspective piece can be a review of a single concept or a few related concepts. These articles may represent an expert opinion or considered point of view, alerts of potential problems, observations, comments, controversies and opinions. It can contain a single concept or several related concepts.
Book review: The aim of a book review is to provide insight and opinion on recently published scholarly books on telemedicine or related topic.
AUTHORSHIP AND RELATED INFORMATION
Note: The International Committee of Medical Journal Editors (ICMJE) has published the “Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals” (ICMJE Recommendations, formerly “Uniform Requirements for Manuscripts”). TMT is sharing, and endeavors to follow, the ICMJE recommendations for scholarly work in medical journals, as it aspires to adhere to the highest standards of scholalrly publication practices. Details may be obtained here. TMT requires these guidelines and recomendations are met for authors submitting papers to TMT for reveiw and publication.
Below you will find the "Role of Authors and Contributors" as outlined by ICMJE. Should you wish for a more detailed explanation, please see click here.
Manuscripts should only be submitted for consideration once authorization of all contributing authors is gathered. The list of authors will include those who can legitimately claim authorship. This includes all those who:
- Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
- Drafting the work or revising it critically for important intellectual content; AND
- Final approval of the version to be published; AND
- Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Authors will meet the conditions of all of the points above. Each author will have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
Obtaining funding, collecting of data, or overall supervision of a research group does not qualify authorship. Contributors who do not meet the criteria above can be listed in the Acknowledgments section of your manuscript submission. See the International Committee of Medical Journal Editors (ICMJE) guidelines for "Non-Author Contributors" on the the bottom of this link.
CRITERIA FOR PUBLICATION
TMT applies rigorous editorial and peer review overseen by a team of professional editors and independent editor experts in the field.
Within the scope of the journal, as noted above, manuscripts should represent:
- Originality and practicality in advancing telehealth and telemedicine in the value based care environment
- Importance to research, practice, or change in the field
- Interest and relevance for those outside the audience
- Rigorous methodology, with conclusions justified by the evidence presented
- Adherence to the highest ethical standards
Article Processing Fee (APC): Is waived at this time
Open access (OA) journals provide unrestricted, immediate online access to peer-reviewed scholarly research.
What does the article-processing charge (APC) cover?
As costs are involved in every stage of the publication process, from peer review to copy editing and hosting the final article on dedicated servers, authors will be asked to pay an APC in order for their article to be published open access. By paying the APC, authors can post the final, published PDF of their article on a non-commercial web site, institutional repository or other non-commercial free public server, immediately on publication.
Why do authors pay article-processing charges (APC)?
TMT is an open access, peer-reviewed journal. It is not a subscription based pubication. To provide open access, the journal charges publication fees for each original research article published. These fees cover the expenses incurred for publication, including the peer review process, journal production, publication, hosting, and archiving, and software license fees.
The full text of research articles published in TMT is immediately accessible on the TMT website for all viewers. To support this we ask authors to pay an open access fee upon acceptance of their manuscript which we have waived at this time. Peer review consideration of research articles is NOT related to the ability to pay. We review papers based strictly on MERIT. The quality and contribution it makes to the sector supersedes the APC.
TMT has a Waiver Policy. We want to encourage open exchange in an evolving and dynamic market giving fair consideration to all submissions. We believe this should NOT be linked to the ability to pay. We review papers based strictly on MERIT. The quality and contribution it makes to the sector supersedes the APC. We believe this is paramount for fair and open exchange.
- There is no charge for students currently enrolled at an academic institution.
- Papers must be evaluated before a waiver determination is made, and based solely on the MERITS of the paper.
- TMT provides a fair and unbiased forum where authors are encouraged to share both positive and negative experience in the telehealth sector. This can help efforts, planned and underway, in the sector. We are committed to providing a fair and objective forum for all perspectives and experiences.
There are no refunds for Open Access articles once published.
There is no fee for non-research articles published.
The TMT editors are not paid, and is voluntary. Editors, editorial board members, and peer reviewers are required to declare all relevant competing interests and do not participate in the review of any submission for which they have a competing interest.
TMT requires all peer reviewers, editorial board members and journal sataff to disclose relevant financial relationships. An individual has a relevant financial relationship if he/she and/or a spouse or partner had a financial relationship in any amount occurring in the last 12 months with a commercial interest (i.e., any entity producing, marketing, re-selling, or distributing health care goods or service consumed by, or used on, patients. Stocks, ICO etc.) Conflict of interest statements are located on the "Editorial Team" drop down menu on the "About Us" tab on the site.
Policy on Content Validation:
- All the recommendations involving clinical medicine must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients.
- All scientific research referred to, reported, or used in justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection and analysis.
We ask TMT peer reviewers if the TMT article submission over which he/she have control contain information about healthcare products or services related to an activity in which he/she will participate and if he/she (or spouse/partner) has had a personal financial relationship in the last 12 months with a commercial interest that produces, markets, re-sells, or distributes health care goods or services consumed by, or used on patients that will be discussed in this article submission. If yes, we ask him/her to disclose the commercial interest and nature of the relationship. The document requires signature and is maintained by on file at TMT. We do our best to avoid onflicts of interest and will endeavor to assign alternate reviewers as needed. Authors may request a particular reveiwer, or not, it is up to the author. Reveiwers, can of course, recuse themselves from reveiwing a manuscript as well.
TMT publishes these articles under a Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license that allows reuse subject only to the use being non-commercial and to the article being fully attributed (http://creativecommons.org/licenses/by-nc/4.0). Articles funded by organizations that mandate publication with a Creative Commons Attribution (CC BY 4.0) license, which permits reuse for commercial purposes subject to the article being fully attributed (http://creativecommons.org/licenses/by/4.0), are published with this license. TMT makes all open access articles freely available on TMT website from the date of publication.
Open access articles can be identified by the Creative Commons copyright statement that appears at the end of the article and takes the following form:
“This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, adapt, enhance this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0.”
“This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, adapt and enhance this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0.”
TMT will also send these articles, without further intervention from the author, to PubMed Central, the National Library of Medicine’s full text article archive, where they will be made fully available in future in PubMed’s open access subset.
Permissions for authors
Authors may use their own articles for the following non-commercial purposes without asking our permission (subject only to acknowledging first publication in TMT and giving a full reference or web link, as appropriate).
Third parties: Permission to reuse
Anyone other than the author of a paper who wants to reproduce an article from TMT needs to seek TMT permission. Fees may apply.
Please contact the publisher at email@example.com for further details.
The content of accepted articles cannot appear in print, on media outlets, or electronic form (including blogs and discussion groups) prior to publication on the TMT website. Abstracts of work may be presented at scientific conferences.
TMT research articles are published under the Creative Commons Attribution (CC BY) license. This requires journalists, PIOs and bloggers to credit TMT as the source and provide a link to the journal and/or the original article in online coverage.
TMT is committed to advancing the use of blockchain in scholarly publishing. Under this partnership, ARTiFACTS and TMT will work together to integrate blockchain technology into the scholarly publishing workflow and collaborate on research to assess the effectiveness of the technology as a tool to improve speed, collaboration, access, transparency, and attribution in scholarly research.
TMT will make its content available on the ARTiFACTS platform and will also provide access for its author/researcher community to start using the platform to establish proof of existence for research outputs, share research artifacts, and provide and receive immutable attribution in real-time during their research. Authors will benefit from the ability to easily and securely share in-process work to speed collaboration and enhance their reputation as research is conducted.
Telehealth and Medicine Today (TMT), is an online peer-review journal available for authors to add to their list of “where” to publish. There are a few items to note when you consider TMT:
- Editorial Mission of Publication: TMT endeavors to assist and inform an evolving health sector in launching and scaling delivery services to achieve sustainable outcomes in telehealth ad medicine within clinically integrated healthcare systems. This includes positive and negative results. One of our journal pillars is to honor success and failure in research. We believe it is the duty of scholarly publications to publish both.
- Turn-around Time: TMTis committed to providing fast turnaround for peer review. Our aim is 7 to 14 business days.
- Caliber of Board Members and Peer Reviewers: The team is a cross section of world-renowned experts bringing depth and breadth of knowledge and curiosity to a collegiate and egalitarian platform. Join the network and help build the community.
- Scholarly Practices: We adhere to ICMJE, COPE, and WAME guidelines and practices. TMT uses the PKP Open Journal Systems (OJS), platform. We seek inclusion on content aggregators and online directories while we await membership to scholarly organizations.
- Portfolio: We are a far-reaching new era portfolio publishing in the telehealth and blockchain sectors. We are committed to sharing knowledge, stimulating thoughts and conversations to build consensus, and promote a path forward in areas that pioneer innovation and change legacy systems, and assist in achieving better health, quality of care, and a more efficient healthcare system. If you share these values, throw your support behind us. It takes a village, and everyone brings something to the table. Opportunities present once—this one is yours to seize now…!
- Indexing: As a new journal, we don’t have an Impact Factor. Without your submissions, we don’t obtain an Impact Factor. As soon as TMT obtains index status, indexing articles will occur retroactively. All articles receive a DOI number. Considering it takes months to publish a paper in some journals—in that time, TMT can have an Index Factor—but it doesn’t happen without your manuscript submission!
TMT has been conceived as a serious scholarly publication to benefit the healthcare sector and the initiatives, pilots, deployments, and outcomes many of you are focused on. Its scope, quality, originality of content sought, and significance of this content, will qualify TMT for inclusion in scholarly databases. We welcome your suggestions, and look forward to working together to achieve the goals both author and publisher need to meet.